Taher, A. T. Et Al. 2025. Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial. LANCET , vol.406, no.10498 , 33-42.

Taher, A. T., Küpesiz, O. A., Tayfun Küpesiz, F., & Erkan, M., (2025). Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial. LANCET , vol.406, no.10498, 33-42.

Taher, Ali Et Al. "Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial," LANCET , vol.406, no.10498, 33-42, 2025

Taher, Ali T. Et Al. "Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial." LANCET , vol.406, no.10498, pp.33-42, 2025

Taher, A. T. Et Al. (2025) . "Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial." LANCET , vol.406, no.10498, pp.33-42.

@article{article, author={Ali T Taher Et Al. }, title={Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial}, journal={LANCET}, year=2025, pages={33-42} }